AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,762,000 | -83.4% | 116,422 | -91.8% | 0.00% | -75.0% |
| Q2 2022 | $10,640,000 | -17.5% | 1,419,176 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $12,897,000 | -9.4% | 1,418,305 | -30.1% | 0.00% | 0.0% |
| Q4 2021 | $14,236,000 | -23.0% | 2,028,787 | +25.1% | 0.00% | -33.3% |
| Q3 2021 | $18,484,000 | -26.5% | 1,621,330 | +3.3% | 0.01% | -25.0% |
| Q2 2021 | $25,132,000 | -11.6% | 1,569,744 | -1.3% | 0.01% | -11.1% |
| Q1 2021 | $28,433,000 | +53.9% | 1,591,132 | +16.4% | 0.01% | +28.6% |
| Q4 2020 | $18,474,000 | +41.1% | 1,367,484 | +23.0% | 0.01% | +40.0% |
| Q3 2020 | $13,090,000 | +6.1% | 1,112,130 | +33.0% | 0.01% | 0.0% |
| Q2 2020 | $12,343,000 | -21.5% | 836,075 | -28.3% | 0.01% | -37.5% |
| Q1 2020 | $15,724,000 | -41.5% | 1,166,021 | +4.9% | 0.01% | -27.3% |
| Q4 2019 | $26,856,000 | +44.5% | 1,111,936 | +15.0% | 0.01% | +37.5% |
| Q3 2019 | $18,583,000 | +23.8% | 967,238 | +90.3% | 0.01% | +14.3% |
| Q2 2019 | $15,016,000 | -20.8% | 508,362 | +27.4% | 0.01% | -22.2% |
| Q1 2019 | $18,956,000 | +27.5% | 399,064 | -3.1% | 0.01% | +28.6% |
| Q4 2018 | $14,864,000 | -26.6% | 411,871 | +23.4% | 0.01% | 0.0% |
| Q3 2018 | $20,254,000 | -6.4% | 333,776 | +4.1% | 0.01% | -30.0% |
| Q2 2018 | $21,648,000 | +42.6% | 320,595 | +14.5% | 0.01% | +42.9% |
| Q1 2018 | $15,183,000 | -14.0% | 279,878 | -5.3% | 0.01% | -12.5% |
| Q4 2017 | $17,650,000 | +25.3% | 295,402 | +1.9% | 0.01% | +14.3% |
| Q3 2017 | $14,084,000 | -8.8% | 289,877 | -1.4% | 0.01% | -12.5% |
| Q2 2017 | $15,442,000 | -4.9% | 293,927 | -17.9% | 0.01% | 0.0% |
| Q1 2017 | $16,238,000 | -8.2% | 358,167 | -23.4% | 0.01% | -20.0% |
| Q4 2016 | $17,696,000 | -21.2% | 467,826 | -21.4% | 0.01% | -23.1% |
| Q3 2016 | $22,465,000 | +713.4% | 595,292 | +279.8% | 0.01% | +550.0% |
| Q2 2016 | $2,762,000 | +33.6% | 156,729 | -7.8% | 0.00% | +100.0% |
| Q1 2016 | $2,068,000 | -50.6% | 170,074 | -1.1% | 0.00% | -50.0% |
| Q4 2015 | $4,188,000 | -4.6% | 171,963 | -30.5% | 0.00% | -33.3% |
| Q3 2015 | $4,389,000 | -27.9% | 247,409 | -28.3% | 0.00% | 0.0% |
| Q2 2015 | $6,088,000 | +81.0% | 344,929 | +221.5% | 0.00% | +50.0% |
| Q1 2015 | $3,363,000 | +181.2% | 107,302 | +161.9% | 0.00% | +100.0% |
| Q4 2014 | $1,196,000 | +48.9% | 40,968 | +5.6% | 0.00% | – |
| Q3 2014 | $803,000 | – | 38,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|